amnion chorion allograft membrane
BiologicalBiologic Amnion chorion allograft membrane derived from placenta of a donor pregnant subject.
Other names: BioXclude™,Snoasis Medical products, USA.
NCT Number: NCT02656732
The present randomized, controlled, parallel-grouped trial included twenty patients (aged 20 to 54 years) suffering from Miller's class I or II gingival recession. Patients were randomly assigned into two equal groups; control group; the coronally advanced flap with the subepithelial connective tissue graft (CAF+SCTG) or the test group; coronally advanced flap with amnion chorion allograft membrane (CAF+AC).
Looking for future studies?
Notify Me20 year–54 year
All sexes
Interventional
Not applicable
The participants were randomly assigned to receive coronally advanced flap (CAF) with amnion chorion membrane or CAF with subepithelial connective tissue graft using a simple randomization procedure with a 1:1 allocation ratio. A computer generated randomization list was drawn up by a faculty member who was not involved in the recruitment. Allocation concealment was achieved by sealed coded opaque envelopes that contained the treatment to be performed to the enrolled subjects based on the randomized numbers. Consequently, patients were allocated to either AC membrane (intervention) or SCTG (control) groups. The sealed envelope containing treatment assignment was opened at time of the surgery and the number was picked by another person other than the operator.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Biologic Amnion chorion allograft membrane derived from placenta of a donor pregnant subject.
Other names: BioXclude™,Snoasis Medical products, USA.
coronally advanced flap with the placement of subepithelial connective tissue graft harvested from the palate
Other names: autogenous connective tissue graft
Time frame: Change in mm from baseline before surgical procedure to follow up at 6 months.
It is measured as the distance from the cemento-enamel junction to the gingival margin representing the amount of root coverage.
Time frame: Change in mm from baseline before surgical procedure to follow up at 6 months.
It is measured as the distance from mesial and distal papillae along cemento-enamel junction.
Time frame: Change in mm from baseline before surgical procedure to follow up at 6 months.
It is measured from the mucogingival junction to the free gingival margin.
Time frame: Change in mm from baseline before surgical procedure to follow up at 6 months.
It is measuring the distance from the base of pocket to the gingival margin.
Time frame: Change in mm from baseline before surgical procedure to follow up at 6 months.
It is measuring the distance from the apical end of periodontal probe to cemento-enamel junction.
Time frame: Change in mm from baseline before surgical procedure to follow up at 6 months.
It is measured by penetrating the gingiva with the periodontal probe down to bone after giving local anesthesia to measure the thickness of gingival tissues
Time frame: score taken after completion of the study at 6 months
The clinical esthetic evaluation was performed without magnification to evaluate gingival margin, marginal tissue contour, soft tissue texture, mucogingival junction alignment and gingival color
Time frame: taken after completion of the study at 6 months
Patients were given certain questions regarding not regretting to perform the surgery, root hypersensitivity and aesthetic satisfaction to be answered at the 6 month follow-up for assessing their satisfaction with the whole procedure.
Cairo University
Other
Clinical Evaluation of Amnion Chorion Membrane in Comparison to Subepithelial Connective Tissue Graft in Gingival Recession Coverage: A Randomized Controlled Clinical Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736833
Gingival Diseases, Gingival Recession
Tanta, Gharbia Governorate, Egypt
View Trial DetailsNCT05470660
Gingival Diseases, Gingival Recession
Cairo, Egypt
View Trial DetailsNCT07291583
Gingival Diseases, Gingival Recession
Ankara, None Selected, Turkey (Türkiye)
View Trial DetailsNCT07616960
Gingival Diseases, Gingival Recession
Taipei, Taiwan
View Trial Details